STRATA Skin Sciences (SSKN) Sets New 12-Month High at $3.67

STRATA Skin Sciences Inc (NASDAQ:SSKN) shares reached a new 52-week high on Thursday . The stock traded as high as $3.67 and last traded at $3.63, with a volume of 9848 shares traded. The stock had previously closed at $3.50.

Several research analysts recently weighed in on SSKN shares. Dawson James started coverage on shares of STRATA Skin Sciences in a research report on Tuesday, September 4th. They issued a “buy” rating for the company. HC Wainwright set a $3.00 target price on shares of STRATA Skin Sciences and gave the company a “buy” rating in a research report on Thursday, May 31st. Zacks Investment Research cut shares of STRATA Skin Sciences from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 1st. Finally, ValuEngine upgraded shares of STRATA Skin Sciences from a “hold” rating to a “buy” rating in a research report on Thursday, July 5th.

The company has a debt-to-equity ratio of 0.22, a quick ratio of 4.20 and a current ratio of 4.77.

STRATA Skin Sciences (NASDAQ:SSKN) last issued its earnings results on Monday, August 13th. The medical device company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.03) by $0.01. The company had revenue of $7.53 million during the quarter, compared to analysts’ expectations of $6.84 million. STRATA Skin Sciences had a negative net margin of 63.07% and a negative return on equity of 27.01%. sell-side analysts expect that STRATA Skin Sciences Inc will post -0.2 earnings per share for the current year.

Institutional investors have recently modified their holdings of the business. Nantahala Capital Management LLC bought a new stake in shares of STRATA Skin Sciences during the 2nd quarter valued at $4,261,000. Menora Mivtachim Holdings LTD. bought a new stake in shares of STRATA Skin Sciences during the 2nd quarter valued at $1,138,000. Renaissance Technologies LLC raised its position in shares of STRATA Skin Sciences by 164.6% during the 2nd quarter. Renaissance Technologies LLC now owns 293,499 shares of the medical device company’s stock valued at $602,000 after acquiring an additional 182,579 shares during the last quarter. Finally, Macquarie Group Ltd. raised its position in shares of STRATA Skin Sciences by 89.7% during the 2nd quarter. Macquarie Group Ltd. now owns 134,033 shares of the medical device company’s stock valued at $275,000 after acquiring an additional 63,393 shares during the last quarter. Institutional investors own 27.47% of the company’s stock.

STRATA Skin Sciences Company Profile (NASDAQ:SSKN)

STRATA Skin Sciences, Inc, a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions.

Featured Article: NASDAQ Stock Market Explained

Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply